Gilead beat revenue and earnings expectations in Q3, according to

© Reuters Gilead profit and revenue beat expectations in Q3. – Gilead Corporation (NASDAQ: ) reported Q3 earnings that beat analysts’ estimates, according to data released on Tuesday.

According to the analyst consensus compiled by Gilead, Gilead’s earnings per share (EPS) were $2.29 on revenue of $7.1B.’s expectations for the upcoming release were previously expected to be $1.91 per share on revenue of $6.81B.

Besides Gilead, there are other companies. Markets report this month’s earnings in the healthcare sector of the NASDAQ Stock Exchange

Eli Lilly previously estimated Q3 earnings at $0.1 per share on revenue of $9.5B, and $-0.2 on revenue of $8.97B.

Meanwhile, UnitedHealth’s most recently reported performance beat analyst forecasts. Q3 earnings were $6.56 per share on revenue of $92.4B, beating analyst estimates for 2020. expects earnings per share to be around $6.33 based on revenue of $91.42B.

Follow the latest developments in company profits with the Earnings Calendar

Leave a Reply

Your email address will not be published. Required fields are marked *